(Q37043551)

17 August 2017

1 reference

title

Benefits and risks of aprotinin use during cardiac surgery (English)

1 reference

17 August 2017

0 references

Judith L Kristeller

1

1 reference

17 August 2017

Brian P Roslund

series ordinal

2

1 reference

17 August 2017

Russell F Stahl

series ordinal

3

1 reference

17 August 2017

language of work or name

English

0 references

publication date

1 January 2008

1 reference

17 August 2017

1 reference

17 August 2017

volume

28

1 reference

17 August 2017

issue

1

1 reference

17 August 2017

page(s)

112-124

1 reference

Perioperative blood transfusion and blood conservation in cardiac surgery: the Society of Thoracic Surgeons and The Society of Cardiovascular Anesthesiologists clinical practice guideline

17 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.1.112

A propensity score case-control comparison of aprotinin and tranexamic acid in high-transfusion-risk cardiac surgery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.1.112

The risk associated with aprotinin in cardiac surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.1.112

Mortality associated with aprotinin during 5 years following coronary artery bypass graft surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.1.112

The antithrombotic and antiinflammatory mechanisms of action of aprotinin

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.1.112

Aprotinin and the systemic inflammatory response after cardiopulmonary bypass

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.1.112

Aprotinin: is it prothrombotic?

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.1.112

Aprotinin and preservation of myocardial function after ischemia-reperfusion injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.1.112

Aprotinin in coronary operation with cardiopulmonary bypass: does "low-dose" aprotinin inhibit the inflammatory response?

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.1.112

Low-dose postoperative aprotinin reduces mediastinal drainage and blood product use in patients undergoing primary coronary artery bypass grafting who are taking aspirin: a prospective, randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.1.112

Ultra-low dose aprotinin decreases transfusion requirements and is cost effective in coronary operations

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.1.112

Identifying patients at risk of intraoperative and postoperative transfusion in isolated CABG: toward selective conservation strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.1.112

Does clopidogrel increase blood loss following coronary artery bypass surgery?

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.1.112

Blood Use in Patients Undergoing Coronary Artery Bypass Surgery: Impact Of Cardiopulmonary Bypass Pump, Hematocrit, Gender, Age, and Body Weight

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.1.112

Randomized controlled trials of aprotinin in cardiac surgery: could clinical equipoise have stopped the bleeding?

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.1.112

Aprotinin use in cardiac surgery patients at low risk for requiring blood transfusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.1.112

Aprotinin in primary valve replacement and reconstruction: a multicenter, double-blind, placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.1.112

Images in cardiovascular medicine. Carotid plaque reduction after medical treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.1.112

Comparison of two strategies for the management of antiplatelet therapy during urgent surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.1.112

Aprotinin reduces bleeding and blood product use in patients treated with clopidogrel before coronary artery bypass grafting

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.1.112

Analyses of coronary graft patency after aprotinin use: results from the International Multicenter Aprotinin Graft Patency Experience (IMAGE) trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.1.112

Meta-analysis comparing the effectiveness and adverse outcomes of antifibrinolytic agents in cardiac surgery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.1.112

Attenuation of neurologic injury during cardiac surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.1.112

Stroke after cardiac surgery: a retrospective analysis of the effect of aprotinin dosing regimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.1.112

Effect of aprotinin on clinical outcomes in coronary artery bypass graft surgery: a systematic review and meta-analysis of randomized clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.1.112

Kidney-specific proteins in patients receiving aprotinin at high- and low-dose regimens during coronary artery bypass graft with cardiopulmonary bypass

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.1.112

Does the combination of aprotinin and angiotensin-converting enzyme inhibitor cause renal failure after cardiac surgery?

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.1.112

A randomized trial of aprotinin (Trasylol) on blood loss, blood product requirement, and myocardial injury in total arterial grafting

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.1.112

Forty years of clinical aprotinin use: a review of 124 hypersensitivity reactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.1.112

Anaphylactic reactions to aprotinin reexposure in cardiac surgery: relation to antiaprotinin immunoglobulin G and E antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.1.112

Risk of anaphylaxis from aprotinin re-exposure during LVAD removal and heart transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.1.112

21 January 2018

Identifiers

DOI

10.1592/PHCO.28.1.112

1 reference

17 August 2017

1 reference